Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study

• Binod Dhakal,
• Mei-Jei Zhang,
• Linda J. Burns,
• Xiaoying Tang,
• Christa Meyer,
• Lih-Wen Mau,
• Ajay K. Nooka,
• Edward Stadtmauer,
• Ivana N Micallef,
• Joseph McGuirk,
• Luciano Costa,
• Mark B. Juckett,
• Nina Shah,
• Richard E. Champlin,
• Saad Z. Usmani,
• Sherif S. Farag,
• Taiga Nishihori,
• Vivek Roy,
• Andrew Bodiford,
• Yvonne J. Barnes,
• Edward J. Drea,
• Parameswaran Hari,
• Mehdi Hamadani

Affiliations

Binod Dhakal

BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee

Mei-Jei Zhang

Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee

Linda J. Burns

CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee

Xiaoying Tang

CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee

Christa Meyer

CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN

Lih-Wen Mau

CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN

Ajay K. Nooka

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA

Edward Stadtmauer

University of Pennsylvania Abramson Cancer Center, Philadelphia, PA

Ivana N Micallef

Division of Hematology, Mayo Clinic, Rochester, MN

Joseph McGuirk

Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City

Luciano Costa

Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL

Mark B. Juckett

Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN

Nina Shah

Division of Hematology-Oncology; University of California San Francisco, San Francisco, CA

Richard E. Champlin

Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston

Saad Z. Usmani

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York

Sherif S. Farag

Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis, IN

Taiga Nishihori

Department of Blood and Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL

Vivek Roy

Blood and Marrow Transplant Program, Mayo Clinic, Jacksonville, FL

Andrew Bodiford

US Medical Affairs – Transplantation, Sanofi, Bridgewater, NJ

Yvonne J. Barnes

US Medical Affairs – Hematology Oncology, Sanofi Specialty Care, Cambridge, MA

Edward J. Drea

US Medical – Oncology Medical Value and Outcomes, Sanofi Specialty Care, Cambridge, MA

Parameswaran Hari

CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee

Mehdi Hamadani

BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee